News
X-ZELL announces strategic expansion in Europe
Lennestadt, February 2021 – Award-winning Singaporean start-up, X-ZELL, has announced the opening of a new international office in Germany. Recently voted the second-most innovative health-tech start-up in the world1, X-ZELL has developed a powerful platform...
X-ZELL welcomes new Head of Clinical Development
Singapore, November 2020 – X-ZELL, a Singapore start-up specialising in early cancer detection, has announced the appointment of Claire Fives as the company’s new Head of Clinical Development. Fives recently served as Associate Director, Clinical Operations, at...
MedTech Innovator names X-ZELL as 2020 Asia Pacific Final Competition Winner
Los Angeles & Singapore, November 2020 (via Business Wire) – MedTech Innovator, the largest accelerator of medical devices in the world, in partnership with Asia Pacific Medical Technology Association (APACMed), today announced X-ZELL as the winner of its 2020...
X-ZELL named second-most innovative health tech start-up in the world
Singapore, November 2020 – X-ZELL placed second in a virtual referendum to determine the world’s most innovative health technology start-up. Fellow Singaporean start-up, Plano, took home the overall win after an eight-week voting process. Organised by global analyst...
World-first cancer screening technology trialled in Singapore
Singapore, November 2020 – Two of Singapore’s leading hospitals and medical research centres, National University Hospital (NUH) and Singapore General Hospital (SGH), are trialling a new diagnostic test capable of detecting traces of early-stage prostate cancer in a...
X-ZELL facing three start-up competition finals in one week
Singapore, November 2020 – Singapore start-up X-ZELL has been nominated for the finals of three high-profile start-up competitions and accelerator programs, all taking place within the same week from 11-18 Nov 2020. World’s Most Innovative Health Tech Start-up...
X-ZELL closes oversubscribed Seed+ round
Singapore, October 2020 – Singapore start-up X-ZELL has closed an oversubscribed Seed+ round led by German industrial service group, Deutsche Industrieanlagen (DIAG). Ranked among the world's most innovative health technology start-ups[1], X-ZELL specialises in the...
X-ZELL selected for prestigious MedTech Innovator Accelerator program
Singapore, July 2020 – X-ZELL is one of 20 start-ups to be selected for MedTech Innovator’s 2020 Asia Pacific Accelerator program. Founded in 2013, MedTech Innovator is a Los Angeles-based non-profit organisation specialising in medical technology and digital health,...
Next generation Cryoimmunostaining™ Suite revealed
Singapore, June 2020 – 18 months after premiering at the 2019 Medlab Asia exhibition in Singapore, X-ZELL’s game-changing Cryoimmunostaining™ Suite is about to receive a facelift. According to X-ZELL’s Head of Medical Devices, Bart Van der Voort, the next generation...
X-ZELL part of Galen Growth’s 2020 HealthTech Cohort
Singapore, May 2020 – X-ZELL is one of 23 start-ups selected to be part of Galen Growth’s inaugural HealthTech Cohort, an acceleration and networking initiative designed to champion healthcare innovation from across Asia. According to Julien de Salaberry, CEO &...
© 2024 X-ZELL Biotech Pte. Ltd.
Find Us